These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34600893)

  • 1. Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae.
    Prajapati J; Rao P; Poojara L; Goswami D; Acharya D; Patel SK; Rawal RM
    Arch Biochem Biophys; 2021 Nov; 712():109048. PubMed ID: 34600893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive in vitro and in silico Assessment on Inhibition of CYP51B and Ergosterol Biosynthesis by Eugenol in Rhizopus oryzae.
    Prajapati J; Rao P; Poojara L; Acharya D; Patel SK; Goswami D; Rawal RM
    Curr Microbiol; 2022 Dec; 80(1):47. PubMed ID: 36538133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Confirmation of the Linkage between the
    Macedo D; Leonardelli F; Dudiuk C; Theill L; Cabeza MS; Gamarra S; Garcia-Effron G
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891608
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular dynamic modeling of CYP51B in complex with azole inhibitors.
    Gao P; Cui YL; Wu RL
    J Biomol Struct Dyn; 2018 May; 36(6):1511-1519. PubMed ID: 28504057
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of lupeol, quercetin, and solasodine on Rhizopus oryzae: A molecular docking and dynamic simulation study.
    Arumuganainar D; Yadalam PK; Alzahrani KJ; Alsharif KF; Alzahrani FM; Alshammeri S; Ahmed SSSJ; Vinothkumar TS; Baeshen HA; Patil S
    J Infect Public Health; 2023 Jan; 16(1):117-124. PubMed ID: 36512968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline Based Monocarbonyl Curcumin Analogs as Potential Antifungal and Antioxidant Agents: Synthesis, Bioevaluation and Molecular Docking Study.
    Nagargoje AA; Akolkar SV; Siddiqui MM; Subhedar DD; Sangshetti JN; Khedkar VM; Shingate BB
    Chem Biodivers; 2020 Feb; 17(2):e1900624. PubMed ID: 31863703
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Point Mutations in
    Abastabar M; Hosseini T; Valadan R; Lagzian M; Haghani I; Aslani N; Badali H; Nouripour-Sisakht S; Nazeri M; Gholami S; Vakili M; Bowyer P; Shokohi T; Hedayati MT
    Microb Drug Resist; 2019 Jun; 25(5):652-662. PubMed ID: 30657433
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
    Kurakado S; Matsumoto Y; Sugita T
    Med Mycol J; 2021; 62(3):53-57. PubMed ID: 34471035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 of fungi: primary target for azole antifungal agents.
    Yoshida Y
    Curr Top Med Mycol; 1988; 2():388-418. PubMed ID: 3288361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.
    Song J; Zhai P; Zhang Y; Zhang C; Sang H; Han G; Keller NP; Lu L
    mBio; 2016 Feb; 7(1):e01919-15. PubMed ID: 26908577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51.
    Matowane RG; Wieteska L; Bamal HD; Kgosiemang IKR; Van Wyk M; Manume NA; Abdalla SMH; Mashele SS; Gront D; Syed K
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):166-177. PubMed ID: 28989052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.
    Bellanger AP; Tatara AM; Shirazi F; Gebremariam T; Albert ND; Lewis RE; Ibrahim AS; Kontoyiannis DP
    J Infect Dis; 2016 Jul; 214(1):114-21. PubMed ID: 26984141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.
    Hargrove TY; Wawrzak Z; Lamb DC; Guengerich FP; Lepesheva GI
    J Biol Chem; 2015 Sep; 290(39):23916-34. PubMed ID: 26269599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.
    Appiah-Opong R; Commandeur JN; van Vugt-Lussenburg B; Vermeulen NP
    Toxicology; 2007 Jun; 235(1-2):83-91. PubMed ID: 17433521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
    Lewis RE; Ben-Ami R; Best L; Albert N; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2013 Mar; 207(5):834-41. PubMed ID: 23242544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.
    Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Shaw KJ; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
    Kachuei R; Khodavaisy S; Rezaie S; Sharifynia S
    J Mycol Med; 2016 Mar; 26(1):17-21. PubMed ID: 26852191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity, main active components and mechanism of Curcuma longa extract against Fusarium graminearum.
    Chen C; Long L; Zhang F; Chen Q; Chen C; Yu X; Liu Q; Bao J; Long Z
    PLoS One; 2018; 13(3):e0194284. PubMed ID: 29543859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.